Navigation Links
Intensified chemotherapy shows promise for children with very high risk form of leukemia
Date:12/10/2012

Young patients with an aggressive form of leukemia who are likely to relapse after chemotherapy treatment can significantly reduce those odds by receiving additional courses of chemotherapy, suggest the findings of a clinical trial led by investigators at Dana-Farber/Children's Hospital Cancer Center in Boston.

The trial leaders will present the results of the Dana-Farber Cancer Institute ALL Consortium study, which involved nearly 500 patients under age 18 with B-precursor acute lymphoblastic leukemia (B-ALL), at the annual meeting of the American Society of Hematology (ASH) conference.

Trial participants received an initial course of "induction" chemotherapy for B-ALL, a cancer of the blood that is one of the most common cancers in children below age 15. After a month of treatment, the patients had a bone marrow sample sent for a test able to measure levels of leukemia that cannot be seen under a microscope.

Thirty-five of the patients were deemed to have a very high risk of relapsing because they retained relatively large numbers of leukemia cells as measured by this test. An additional 16 patients were also considered very high-risk because their leukemia cells had certain chromosomal abnormalities.

These 51 patients then received an intensified treatment regimen consisting of two additional rounds of chemotherapy using agents not typically given to newly diagnosed patients with B-ALL. This was followed by an intensified consolidation phase of therapy to keep the disease in remission, and then a standard maintenance phase to further deter the disease from returning.

Investigators estimate that, five years after reaching complete remission, the rate of event-free survival (a measure of survival without relapse or development of another cancer) was 76 percent for these very high-risk patients. By contrast, less than half of similar patients who receive standard chemotherapy reach the five-year mark without relapsing.'/>"/>

Contact: Teresa Herbert
teresa_herbert@dfci.harvard.edu
Dana-Farber Cancer Institute
Source:Eurekalert

Page: 1 2

Related medicine news :

1. UCLA cancer scientists identify liposarcoma tumors that respond to chemotherapy
2. Immune system kill switch could be target for chemotherapy and infection recovery
3. Mayo Clinic: Less invasive surgery detects residual breast cancer in lymph nodes after chemotherapy
4. Improving chemotherapy effectiveness by acting on the immune system
5. Nanomedicine breakthrough could improve chemotherapy for childhood cancer
6. Researchers develop non-invasive technique for predicting patients response to chemotherapy
7. Recent findings may help to fight melanomas resistance to chemotherapy
8. Key discovered to how chemotherapy drug causes heart failure
9. Researchers reveal underlying mechanism of powerful chemotherapy for prostate cancer treatment
10. UCI researchers find cause of chemotherapy resistance in melanoma
11. Weizmann Institutes mathematical model may lead to safer chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... NC (PRWEB) June 02, 2015 Food ... hosting its sixth annual “Thriller on the Griller” events, ... Carolina and South Carolina locations. Each event will raise ... dedicated to restoring a sense of self, restoring the ... and our military families. , Through these events, ...
(Date:6/2/2015)... June 02, 2015 Highly qualified dental care ... plan to drive prolific change in the dental tourism industry ... Team Dental Clinic offers a full range of superior ... structure for dental tourism. , Partnered with a top ... committed to advancing dentistry and has earned a reputation as ...
(Date:6/2/2015)... The term “Augmented Reality” was coined in ... the real world. Since then many promising technologies have ... map of the vasculature on the surface of the ... AccuVein, the leader in vein visualization, exemplifies this growth ... such widespread adoption of its AccuVein AV400 devices that ...
(Date:6/2/2015)... “ Radaris ” was featured on NewsWatch as ... the latest and coolest applications on the market for iOS, ... technology expert, conducted the app review and shared with viewers ... a person. , According to Psychology Today, humans are a ... explain that curiosity is a part of human development. People ...
(Date:6/2/2015)... FL (PRWEB) June 02, 2015 MedPro ... staffing services to healthcare facilities, today announced the worldwide ... and effective mobile tool to help candidates find best ... Glassdoor survey released in 2014, 9 in 10 job ... during their job search. , The MedPro Top Jobs ...
Breaking Medicine News(10 mins):Health News:Food Lion to Launch “Thriller on the Griller” Events to Benefit Military Families through Hope For The Warriors® 2Health News:Food Lion to Launch “Thriller on the Griller” Events to Benefit Military Families through Hope For The Warriors® 3Health News:Team Dental Clinic Unveils Plan to Drive Change in the Dental Tourism Industry 2Health News:Team Dental Clinic Unveils Plan to Drive Change in the Dental Tourism Industry 3Health News:Vein Visualization Emerges as Premier Augmented Reality Application 2Health News:A Comprehensive People Search Application Was Featured on NewsWatch Television 2Health News:MedPro Healthcare Staffing Launches New MedPro Top Jobs App To Facilitate Job Search For Healthcare Professionals 2
... French study in rats finds olanzapine changes metabolism in ... of the antipsychotic medication olanzapine may put a person ... 2 diabetes, new findings show. , A team of ... found that, after consuming olanzapine over several weeks, the ...
... the Country Gather to Discuss, Interactive Patient Care Topics and ... ... Patient Experience, WASHINGTON, April 7, 2008 ... today,announced the kick-off of GetConnected2008. Designed exclusively for the,GetWellNetwork community, ...
... Advanced Life Sciences,Holdings, Inc. (Nasdaq: ADLS ), ... live webcast at 8:30 am (EDT) on Thursday, April ... discuss the Company,s April 7, 2008,meeting with The US ... for the Company,s novel once-a-day oral antibiotic, cethromycin,as a ...
... is caused by mutations that allow defective blood ... effective therapies it is crucial to know which mutations ... leukaemic cells. Researchers from the European Molecular Biology Laboratory ... the Universities of Harvard, USA, and Lund, Sweden, have ...
... N.Y., April 7, 2008 CardWorks Servicing, LLC,("CardWorks") ... known as Cardholder Management Services, LLC ("CMS"), announced,today ... the new HumanaAdvance,Visa Card. CardWorks will partner with ... offer the HumanaAdvance Visa. Humana,is one of the ...
... treatment aren,t known, researchers say , , MONDAY, April 7 ... bone density and reduce bone loss in older men ... prevent osteoporosis, a new study suggests. , Testosterone ... muscle mass in some men. However, the hormone treatment ...
Cached Medicine News:Health News:Antipsychotic Drug Boosts Risk of Heart Disease, Diabetes 2Health News:GetWellNetwork Kicks Off GetConnected2008, First Annual Users Conference 2Health News:GetWellNetwork Kicks Off GetConnected2008, First Annual Users Conference 3Health News:Advanced Life Sciences to Host Conference Call to Discuss April 7th Meeting with FDA 2Health News:Advanced Life Sciences to Host Conference Call to Discuss April 7th Meeting with FDA 3Health News:An unexpected way to cause leukemia 2Health News:CardWorks Named Servicer of Choice for Innovative Credit Card for Healthcare Services 2Health News:CardWorks Named Servicer of Choice for Innovative Credit Card for Healthcare Services 3Health News:Testosterone Therapy May Reduce Bone Loss in Older Men 2
(Date:6/2/2015)... , June 02, 2015 Research and Markets ( ... Incision Closures - Global Strategic Business Report" report to ... for the US, Canada , ... Asia-Pacific , Latin America , and ... markets for Surgical Incision Closures in US$ Million by the ...
(Date:6/2/2015)... 2, 2015  Only a quarter of physicians who ... patients they prescribe them to, according to new survey ... Medicine (BUSM) and myCME , Haymarket Medical ... Alford, M.D. , director of BUSM,s Safe and ... said, "This indicates a critical need for provider education ...
(Date:6/2/2015)... June 2, 2015  ErgoNurse, the leader in bedside safety ... products in the United States , have ... long-term care and skilled nursing markets. ... Thousands of ... fully take advantage of the ErgoNurse products to stop unnecessarily ...
Breaking Medicine Technology:Surgical Incision Closures - Global Strategic Business Report 2015 2Survey Results Show Few Doctors Are Very Confident Managing Patients on Opioids 2ErgoNurse and Briggs Healthcare Positioned to Completely Eliminate the Unnecessary Cost of Healthcare-Related Back Injuries 2
... July 22, and OSAKA, Japan, July 23 ... Takeda Global Research & Development Center, Inc., a wholly ... U.S. Food and Drug Administration (FDA) that the FDA ... for the fixed-dose combination (FDC) of alogliptin and ACTOS((R)) ...
... , MENLO PARK, Calif., July 22 Apieron, ... positive coverage policy for the measurement of exhaled nitric oxide ... peer-reviewed evidence is sufficient to support benefit coverage for the ... the measurement of exhaled nitric oxide is considered medically necessary ...
Cached Medicine Technology:Takeda Provides Update on the Investigational Fixed-Dose Combination of alogliptin and ACTOS(R) (pioglitazone HCl) 2Takeda Provides Update on the Investigational Fixed-Dose Combination of alogliptin and ACTOS(R) (pioglitazone HCl) 3CareFirst BCBS Covers eNO Measurement for Diagnosis, Asthma Treatment 2
... an enterprise visibility solution that allows ... effectiveness, and increase patient satisfaction. ... systems and geospatial visual technologies with ... a real time patient care model ...
MONOJECT SUPRA/HONE Blood Collection Needles - Thin Wall...
... are preominantly used for routine blood collection. ... of the needle protective cap simplifies visual ... example, yellow symbolises the needle dimension 20 ... mm) and black 22 G (0.70 mm). ...
ScanGel® Centrifuge...
Medicine Products: